patients with severe gastrointestinal disease or gastroparesis may not be suitable candidates Hypersensitivity reactions : Including anaphylaxis, have been reported rarely Injection site reactions , including erythema, pruritus, or induration, occur in approximately 25% of patients and are generally self-limited
Recently, it became one of the most important drug targets in cardiovascular medicine
The similarity in their TMD interaction patterns is consistent with the strong correlation in the impact of TMD mutagenesis for these two agonists (Fig
BPC-157 is a synthetic peptide derived from Body Protection Compound (BPC), a naturally occurring protein in the human stomach
Two format notes
Lonjou C, Borot N, Sekula P, Ledger N, Thomas L, Halevy S, Naldi L, Bouwes-Bavinck JN, Sidoroff A, de Toma C, Schumacher M, Roujeau JC, Hovnanian A, Mockenhaupt M (2008) A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs